New cell therapy TAK-007 tested in hard-to-treat lymphoma patients
NCT ID NCT05020015
First seen Mar 31, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests a new treatment called TAK-007 in adults with a type of blood cancer called B-cell Non-Hodgkin Lymphoma that has returned or not improved after prior therapy. Participants first receive a short course of chemotherapy to prepare their body, then get one or three doses of TAK-007. The main goals are to check for side effects and see if the lymphoma shrinks or disappears. About 27 people are taking part in this early-phase study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California, 90048, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
DUHS Duke Blood Cancer Center
Durham, North Carolina, 27705, United States
-
MedStar Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Saint Davids South Austin Medical Center
Austin, Texas, 78704, United States
-
Sylvester Comprehensive Cancer Center University of Miami Hospitals and Clinics
Miami, Florida, 33136, United States
-
Thomas Jefferson University Sidney Kimmer Cancer Center, Clinical Research Organization
Philadelphia, Pennsylvania, 19107, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.